LU62071A1 - - Google Patents

Info

Publication number
LU62071A1
LU62071A1 LU62071DA LU62071A1 LU 62071 A1 LU62071 A1 LU 62071A1 LU 62071D A LU62071D A LU 62071DA LU 62071 A1 LU62071 A1 LU 62071A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU62071A1 publication Critical patent/LU62071A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LU62071D 1969-11-17 1970-11-16 LU62071A1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
LU62071A1 true LU62071A1 (da) 1971-08-12

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
LU62071D LU62071A1 (da) 1969-11-17 1970-11-16

Country Status (26)

Country Link
US (1) US3666856A (da)
JP (1) JPS5429520B1 (da)
AT (1) AT309696B (da)
BE (1) BE759011A (da)
BR (1) BR6915136D0 (da)
CA (1) CA967564A (da)
CH (2) CH555344A (da)
CS (1) CS181701B2 (da)
DE (1) DE2056327C2 (da)
DK (1) DK128117B (da)
ES (2) ES385590A1 (da)
FI (1) FI54315C (da)
FR (1) FR2073364B1 (da)
GB (2) GB1338905A (da)
HU (1) HU163812B (da)
IE (1) IE34737B1 (da)
IL (1) IL35658A (da)
LU (1) LU62071A1 (da)
MC (1) MC869A1 (da)
NL (1) NL171589C (da)
NO (1) NO128156B (da)
PL (1) PL81167B1 (da)
SE (1) SE385374B (da)
YU (2) YU35033B (da)
ZA (1) ZA707722B (da)
ZM (1) ZM12970A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
ATE128141T1 (de) * 1988-03-16 1995-10-15 Scripps Research Inst Als therapeutische mittel verwendbare substituierte adeninderivate.
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004452A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
DE2056327A1 (de) 1971-06-03
ES385590A1 (es) 1973-10-01
ZA707722B (en) 1972-06-28
AT309696B (de) 1973-08-27
IE34737L (en) 1971-05-17
FR2073364A1 (da) 1971-10-01
MC869A1 (fr) 1971-09-28
GB1338906A (en) 1973-11-28
DK128117B (da) 1974-03-04
NO128156B (da) 1973-10-08
ZM12970A1 (en) 1972-07-21
FI54315B (fi) 1978-07-31
IE34737B1 (en) 1975-08-06
CH555833A (de) 1974-11-15
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
YU35033B (en) 1980-06-30
IL35658A0 (en) 1971-01-28
CH555344A (de) 1974-10-31
YU280670A (en) 1979-12-31
BE759011A (fr) 1971-05-17
NL171589C (nl) 1983-04-18
CS181701B2 (en) 1978-03-31
NL7016766A (da) 1971-05-19
FI54315C (fi) 1978-11-10
FR2073364B1 (da) 1974-03-22
HU163812B (da) 1973-10-27
JPS5429520B1 (da) 1979-09-25
NL171589B (nl) 1982-11-16
US3666856A (en) 1972-05-30
BR6915136D0 (pt) 1973-04-19
SE385374B (sv) 1976-06-28
PL81167B1 (da) 1975-08-30
IL35658A (en) 1974-10-22
DE2056327C2 (de) 1984-10-11
CA967564A (en) 1975-05-13
YU35034B (en) 1980-06-30
YU201978A (en) 1979-12-31

Similar Documents

Publication Publication Date Title
FR2073364B1 (da)
AU465452B2 (da)
AU429630B2 (da)
AU450150B2 (da)
CS148820B1 (da)
AU442375B2 (da)
AU470301B1 (da)
AU427401B2 (da)
CS150642B2 (da)
AU438128B2 (da)
AU417208B2 (da)
AU428129B2 (da)
AU470661B1 (da)
AU425297B2 (da)
AU428074B2 (da)
AU442538B2 (da)
AU442535B2 (da)
AU442463B2 (da)
AU442380B2 (da)
AU428131B2 (da)
AU442357B2 (da)
AU442322B2 (da)
AU442285B2 (da)
AU4923469A (da)
CS149294B1 (da)